A Phase 1 Randomized, Double-Blinded, Placebo-controlled, Dose-Escalation Study to Assess the Safety, Tolerability and Immunogenicity of Live Attenuated, Oral Shigella WRSS1 Vaccine in Bangladeshi Toddlers (12 to 24 Months Old)
Latest Information Update: 18 Oct 2016
At a glance
- Drugs Shigella sonnei vaccine (Primary)
- Indications Shigella infections
- Focus Adverse reactions
- 18 Oct 2016 New trial record